Comparison of Conbercept with Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion.

CONCLUSION: Intravitreal injection of conbercept is shown to be safe and effective for the treatment of ME secondary to BRVO, based on 6-month follow-up data. PMID: 28441077 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28441077?dopt=Abstract

Source: Current Eye Research - April 25, 2017 Category: Opthalmology Authors: Li F, Sun M, Guo J, Ma A, Zhao B Tags: Curr Eye Res Source Type: research

More News: Lucentis | Ranibizumab Injection | Statistics | Study